AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Oncolytic viruses: A novel treatment strategy for breast cancer

Mohammad Javanbakhta( ), Sanaz Tahmasebzadehb( ), Luca Cegolonc,d, Nasrin Gholamie, Mandana Kashakif, Hassan Nikoueinejada, Mohamad Mozafarig, Mahsa Mozaffarih, Shi Zhaoi, Mostafa Khafaeij, Morteza Izadik, Saeid Fathil, Reza Akhavan-Sigarim
Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran 1435916471, Iran
Mehrestan Health Network, Iranshahr University of Medical Sciences, Iranshahr 9966118984, Iran
University of Trieste, Department of Medical, Surgical & Health Sciences, Trieste 34128, Italy
University Health Agency Giuliano-Isontina (ASUGI), Public Health Department, Trieste, Italy
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz 5167956561, Iran
Shahid Akbarabadi Clinical Research Development Unit (ShACRDU), Iran University of Medical Sciences (IUMS), Tehran 1997673144, Iran
Department of General Surgery, Urmia University of Medical Science, Urmia 57147, Iran
Department of Pediatrics, Iran University of Medical Sciences, Tehran 1449614535, Iran
JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong Special Administrative Region 999077, China
Human Genetics Research Center, Baqiyatallah University of Medical Sciences, Tehran 169875931, Iran
Health Research Center, Baqiyatallah University of Medical Sciences, Tehran 1435916471, Iran
Razi Vaccine and Serum Research Institute, Agriculture Research, Education and Extension Organization (AREEO), Karaj 11365-1558, Iran
Department of Neurosurgery, University Medical Center, Tuebingen 72076, Germany

Peer review under responsibility of Chongqing Medical University.

Show Author Information

Abstract

Breast cancer, an unceasingly occurring neoplasm, is one of the major determinants of mortality in women. Several ineffective attempts have been pursued using with conventional therapies against breast cancer. Resistance to existing therapies and their respective debilitating adverse effects have led research toward a new era of cancer treatment using viruses. Virotherapy constitutes a developing treatment modality with multiple mechanisms of therapeutic activity in which the viruses can be directly oncolyticand can express transgenes or induce host immune response against tumor cells. Several different DNA- and RNA-containing viruses have been considered for virotherapy of breast cancer including adenovirus, herpes virus, vaccinia, reovirus, Newcastle Disease virus, measles virus and vesicular stomatitis virus. This review aims to summarize the viro-therapeutical agents against breast malignancies. Key Scientific Concepts of Review: In this review paper, we proposed a new strategy to virus’s combinatorial treatments using several kinds of transgenes and drugs. These recombinant viruses have provided evidence of treatment efficacy against human breast cancer.

References

【1】
【1】
 
 
Genes & Diseases
Pages 430-446

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Javanbakht M, Tahmasebzadeh S, Cegolon L, et al. Oncolytic viruses: A novel treatment strategy for breast cancer. Genes & Diseases, 2023, 10(2): 430-446. https://doi.org/10.1016/j.gendis.2021.11.011

931

Views

17

Downloads

17

Crossref

18

Web of Science

19

Scopus

1

CSCD

Received: 30 July 2021
Revised: 27 September 2021
Accepted: 19 November 2021
Published: 16 December 2021
© 2021 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).